首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 核酸藥物

市場調查報告書

商品編碼

1609713

2025-2033 年日本胜肽治療市場報告（按類型、製造商類型、合成技術、給藥途徑、應用和地區）

Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年日本胜肽治療IMARC Group規模達25.927億美元。對快速、精確的糖尿病治療方法的需求日益成長，以及人們越來越傾向於透過整容手術來減輕皮膚老化的影響，這主要推動了市場的成長。

胜肽是高效且特異的訊號分子，可附著在特定細胞表面受體（包括離子通道和 G 蛋白偶聯受體 (GPCR)）上，啟動細胞內反應。在製藥領域，它們被用來開發創新的再生療法，能夠針對各種類型的細胞並影響其反應。與其他治療替代方案相比，這些療法毒性較小，通常安全且耐受性良好。因此，它們在日本各地的臨床應用中越來越受歡迎，用於治療癌症、損傷、傳染病、代謝紊亂和美學問題等疾病。

日本胜肽治療市場趨勢：

急性和慢性疾病的盛行率不斷上升，加上醫療服務的改善，是對創新療法開發中對胜肽的需求產生積極影響的一個突出因素，這主要推動了市場的成長。此外，胜肽也用於藥妝過程中以減輕皮膚老化的影響。再加上人們對自己外表的認知不斷增強，以及保持皮膚年輕和健康的願望，正在推動美容治療和基於胜肽的療法在全球範圍內的採用。此外，新合成技術的引入減少了注射頻率並增強了胜肽治療劑的穩定性和其他物理屬性，這使得它們在糖尿病患者的注射中廣泛使用。再加上糖尿病發生率的增加以及對快速、精確治療方法的偏好，正在推動肽療法相對於口服藥物的使用。此外，個人化和標靶治療的新興趨勢正在推動對多功能肽基材料的需求，這是另一個重要的生長誘導因素。除此之外，對開發用於自體免疫和發炎性疾病的新型胜肽療法的投資不斷增加，預計將在未來幾年創造有利的市場前景。

日本胜肽治療市場細分：

類型見解：

創新的
通用的

製造商洞察類型：

外包
內部

合成技術見解：

固相胜肽合成
液相胜肽合成
混合技術

管理見解的途徑：

注射用
口服
其他

應用見解：

胃腸道疾病
神經系統疾病
代謝紊亂
癌症
其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本胜肽治療市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本胜肽治療市場有何影響？
日本肽治療市場按類型分類是怎樣的？
日本肽治療市場按製造商類型分類是怎樣的？
基於合成技術的日本胜肽治療市場的細分是什麼？
日本肽治療市場依給藥途徑分類是怎樣的？
日本肽治療市場的應用如何？
日本肽治療市場價值鏈的各個階段是什麼？
日本肽療法的關鍵促進因素和挑戰是什麼？
日本胜肽治療市場的結構如何？
日本肽治療市場的競爭程度如何？

本報告回答的關鍵問題：

日本胜肽治療市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本胜肽治療市場有何影響？
日本肽治療市場按類型分類是怎樣的？
日本肽治療市場按製造商類型分類是怎樣的？
基於合成技術的日本胜肽治療市場的細分是什麼？
日本肽治療市場依給藥途徑分類是怎樣的？
日本肽治療市場的應用如何？
日本肽治療市場價值鏈的各個階段是什麼？
日本肽療法的關鍵促進因素和挑戰是什麼？
日本胜肽治療市場的結構如何？
日本肽治療市場的競爭程度如何？

固相胜肽合成
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
液相胜肽合成
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
混合技術
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 9 章：日本胜肽治療市場 - 細分：依給藥途徑分類

注射用
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
口服
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 10 章：日本胜肽治療市場 - 細分：按應用分類

胃腸道疾病
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
神經系統疾病
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
代謝紊亂
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
癌症
- 概述
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）
其他
- 歷史與當前市場趨勢（2019-2024）
- 市場預測（2025-2033）

第 11 章：日本胜肽治療市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 12 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 13 章：日本胜肽治療市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 14 章：附錄

簡介目錄

Product Code: SR112024A18531

Japan peptide therapeutics market size reached USD 2,592.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,776.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.37% during 2025-2033. The inflating need for fast and precise treatment methods to cure diabetes, along with the increasing inclination among individuals towards cosmetic procedures to mitigate the effects of skin aging, is primarily driving the market growth.

Peptides are highly effective and specific signaling molecules that attach to particular cell surface receptors, including ion channels and G protein-coupled receptors (GPCRs), initiating intracellular responses. In the pharmaceutical sector, they are utilized to develop innovative regenerative therapies capable of targeting various types of cells and influencing their reactions. These therapies, in comparison to other treatment alternatives, are less toxic, generally safe, and well-tolerated. Consequently, they are becoming increasingly popular in clinical applications throughout Japan for the treatment of conditions such as cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Japan Peptide Therapeutics Market Trends:

The increasing prevalence of both acute and chronic illnesses, alongside improved access to medical services, stands as a prominent factor that is positively impacting the demand for peptides in the development of innovative therapies, which is primarily driving the market growth. Additionally, peptides are employed in cosmeceutical procedures to mitigate the effects of skin aging. This, combined with the growing awareness among individuals about their physical appearance and the desire to maintain youthful and healthy skin, is propelling the adoption of cosmetic treatments and peptide-based therapeutics worldwide. Furthermore, the introduction of new synthetic techniques that reduce the frequency of injections and enhance the stability and other physical attributes of peptide therapeutics has led to their widespread use in injections for diabetic patients. This, in conjunction with the increasing incidence of diabetes and a preference for rapid and precise treatment methods , is driving the utilization of peptide therapeutics over oral medications. Moreover, the emerging trend of personalized and targeted therapies is driving the demand for versatile peptide-based materials, which is acting as another significant growth-inducing factor. Alongside this, the growing investment in the development of novel peptide therapeutics for autoimmune and inflammatory conditions is expected to create a favorable market outlook in the coming years.

Japan Peptide Therapeutics Market Segmentation:

Type Insights:

Innovative
Generic

Type of Manufacturer Insights:

Outsourced
In-house

Synthesis Technology Insights:

Solid Phase Peptide Synthesis
Liquid Phase Peptide Synthesis
Hybrid Technology

Routes of Administration Insights:

Parenteral
Oral
Others

Application Insights:

Gastrointestinal Disorders
Neurological Disorders
Metabolic Disorders
Cancer
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan peptide therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan peptide therapeutics market?
What is the breakup of the Japan peptide therapeutics market on the basis of type?
What is the breakup of the Japan peptide therapeutics market on the basis of type of manufacturer?
What is the breakup of the Japan peptide therapeutics market on the basis of synthesis technology?
What is the breakup of the Japan peptide therapeutics market on the basis of routes of administration?
What is the breakup of the Japan peptide therapeutics market on the basis of application?
What are the various stages in the value chain of the Japan peptide therapeutics market?
What are the key driving factors and challenges in the Japan peptide therapeutics?
What is the structure of the Japan peptide therapeutics market and who are the key players?
What is the degree of competition in the Japan peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Peptide Therapeutics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Peptide Therapeutics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Peptide Therapeutics Market - Breakup by Type

6.1 Innovative
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Generic
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Peptide Therapeutics Market - Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 In-house
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Peptide Therapeutics Market - Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Hybrid Technology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Peptide Therapeutics Market - Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Peptide Therapeutics Market - Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Neurological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Metabolic Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Cancer
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)

11 Japan Peptide Therapeutics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Peptide Therapeutics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis